Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Effects of Dapagliflozin on Myocardial Gene Expression in BTBR Mice with Type 2 Diabetes
Authors
Keywords
-
Journal
CARDIOVASCULAR DRUGS AND THERAPY
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-11-02
DOI
10.1007/s10557-023-07517-1
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Single-cell RNA-seq of heart reveals intercellular communication drivers of myocardial fibrosis in diabetic cardiomyopathy
- (2023) Wei Li et al. eLife
- WCN23-0761 SGLT2 INHIBITOR TREATMENT MAY ENHANCE KIDNEY OXYGENATION AND ATTENUATE HIF1A EXPRESSION IN YOUNG PERSONS WITH TYPE 2 DIABETES
- (2023) V. Nair MS et al. Kidney International Reports
- Empagliflozin Alleviates Left Ventricle Hypertrophy in High-Fat-Fed Mice by Modulating Renin Angiotensin Pathway
- (2022) Juliana Cordovil Cotrin et al. JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM
- SGLT2 Inhibitors and Ketone Metabolism in Heart Failure
- (2022) Huitzilihuitl Saucedo-Orozco et al. Journal of Lipid and Atherosclerosis
- Direct cardiac effects of SGLT2 inhibitors
- (2022) Sha Chen et al. Cardiovascular Diabetology
- Metformin Protects against Diabetic Cardiomyopathy: An Association between Desmin–Sarcomere Injury and the iNOS/mTOR/TIMP-1 Fibrosis Axis
- (2022) Amal F. Dawood et al. Biomedicines
- Characterization of the SGLT2 Interaction Network and Its Regulation by SGLT2 Inhibitors: A Bioinformatic Analysis
- (2022) Zofia Wicik et al. Frontiers in Pharmacology
- Efficacy and safety of dapagliflozin in patients with heart failure with mildly reduced or preserved ejection fraction by baseline glycaemic status (DELIVER): a subgroup analysis from an international, multicentre, double-blind, randomised, placebo-controlled trial
- (2022) Silvio E Inzucchi et al. Lancet Diabetes & Endocrinology
- High Glucose Induced Smad3 Linker Phosphorylation and CCN2 Expression is Inhibited by Dapagliflozin in a Diabetic Tubule Epithelial Cell Model
- (2021) Xinlu Pan et al. BIOSCIENCE REPORTS
- Deletion of Smad3 protects against diabetic myocardiopathy in db/db mice
- (2021) Li Dong et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Activation of HIF1α Rescues the Hypoxic Response and Reverses Metabolic Dysfunction in the Diabetic Heart
- (2021) Maria da Luz Sousa Fialho et al. DIABETES
- SGLT2 inhibition reduces cellular senescence in the diabetic kidney by promoting ketone body‐induced NRF2 activation
- (2021) Mi Na Kim et al. DIABETES OBESITY & METABOLISM
- Therapeutic potential of targeting oxidative stress in diabetic cardiomyopathy
- (2021) Nikole J. Byrne et al. FREE RADICAL BIOLOGY AND MEDICINE
- Cardiac metallothionein overexpression rescues diabetic cardiomyopathy in Akt2‐knockout mice
- (2021) Shan Huang et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- Influence of SGLT2 Inhibitor Treatment on Urine Antioxidant Status in Type 2 Diabetic Patients: A Pilot Study
- (2021) Diana Nabrdalik-Leśniak et al. Oxidative Medicine and Cellular Longevity
- Effects of Sodium‐Glucose Linked Transporter 2 Inhibition With Ertugliflozin on Mitochondrial Function, Energetics, and Metabolic Gene Expression in the Presence and Absence of Diabetes Mellitus in Mice
- (2021) Dominique Croteau et al. Journal of the American Heart Association
- Mechanism of Ferroptosis and Its Role in Type 2 Diabetes Mellitus
- (2021) Wenxin Sha et al. Journal of Diabetes Research
- Follistatin Attenuates Myocardial Fibrosis in Diabetic Cardiomyopathy via the TGF-β–Smad3 Pathway
- (2021) Yinhui Wang et al. Frontiers in Pharmacology
- The effects of exercise training on cardiac matrix metalloproteinases activity and cardiac function in mice with diabetic cardiomyopathy
- (2021) Eleni Dede et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- N-Acetyl Cysteine, Selenium, and Ascorbic Acid Rescue Diabetic Cardiac Hypertrophy via Mitochondrial-Associated Redox Regulators
- (2021) Iram Mushtaq et al. MOLECULES
- Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking
- (2021) Ning Zhu et al. Journal of Diabetes Research
- Axl Is Essential for in-vitro Angiogenesis Induced by Vitreous From Patients With Proliferative Diabetic Retinopathy
- (2021) Wenyi Wu et al. Frontiers in Medicine
- Sodium–glucose cotransporter 2 inhibitor Dapagliflozin attenuates diabetic cardiomyopathy
- (2020) M. Arow et al. Cardiovascular Diabetology
- Empagliflozin improved systolic blood pressure, endothelial dysfunction and heart remodeling in the metabolic syndrome ZSF1 rat
- (2020) Sin-Hee Park et al. Cardiovascular Diabetology
- Dapagliflozin Suppresses Hepcidin And Increases Erythropoiesis
- (2020) Husam Ghanim et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Salvianolic acid B improves myocardial function in diabetic cardiomyopathy by suppressing IGFBP3
- (2020) Chang-ling Li et al. JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY
- Dapagliflozin and Ticagrelor Have Additive Effects on the Attenuation of the Activation of the NLRP3 Inflammasome and the Progression of Diabetic Cardiomyopathy: an AMPK–mTOR Interplay
- (2020) Huan Chen et al. CARDIOVASCULAR DRUGS AND THERAPY
- Dapagliflozin, a sodium glucose cotransporter 2 inhibitors, protects cardiovascular function in type-2 diabetic murine model
- (2020) Sohair Saleh et al. JOURNAL OF GENETICS
- Mechanisms Leading to Differential Hypoxia Inducible Factor Signaling in the Diabetic Kidney: Modulation by SGLT2 Inhibitors and Hypoxia Mimetics
- (2020) Milton Packer AMERICAN JOURNAL OF KIDNEY DISEASES
- Dapagliflozin Activates Neurons in the Central Nervous System and Regulates Cardiovascular Activity by Inhibiting SGLT-2 in Mice
- (2020) Thiquynhnga Nguyen et al. Diabetes Metabolic Syndrome and Obesity-Targets and Therapy
- Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells
- (2020) Laween Uthman et al. CARDIOVASCULAR DRUGS AND THERAPY
- Growth arrest‐specific 6 modulates adiponectin expression and insulin resistance in adipose tissue
- (2020) Sheng‐Chiang Su et al. Journal of Diabetes Investigation
- ROS- and HIF1α-dependent IGFBP3 upregulation blocks IGF1 survival signaling and thereby mediates high-glucose-induced cardiomyocyte apoptosis
- (2019) Yao-Te Huang et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Is the placental proteome impaired in well-controlled gestational diabetes?
- (2019) Silvia Burlina et al. JOURNAL OF MASS SPECTROMETRY
- Overexpression of Axl reverses endothelial cells dysfunction in high glucose and hypoxia
- (2019) Zuo Pei-Yuan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- SGLT2 inhibition with empagliflozin attenuates myocardial oxidative stress and fibrosis in diabetic mice heart
- (2019) Chenguang Li et al. Cardiovascular Diabetology
- Activator protein-1 and caspase 8 mediate p38α MAPK-dependent cardiomyocyte apoptosis induced by palmitic acid
- (2019) Charles C. Oh et al. APOPTOSIS
- Dapagliflozin Attenuates Cardiac Remodeling in Mice Model of Cardiac Pressure Overload
- (2019) Lin Shi et al. AMERICAN JOURNAL OF HYPERTENSION
- Exenatide Protects Against Cardiac Dysfunction by Attenuating Oxidative Stress in the Diabetic Mouse Heart
- (2019) Wei Ding et al. Frontiers in Endocrinology
- Abstract P190: Transcriptomic Data Analysis Reveals Sex-Related Differences in the Interplay Between Toll-Like Receptor 4 and Heat-Shock Protein 70 in the Aorta of Type 2 Diabetic Donors
- (2019) Amanda Almeida De Oliveira et al. HYPERTENSION
- Effects of empagliflozin on nondiabetic salt-sensitive hypertension in uninephrectomized rats
- (2019) Sua Kim et al. HYPERTENSION RESEARCH
- Long-term moderate intensity exercise alleviates myocardial fibrosis in type 2 diabetic rats via inhibitions of oxidative stress and TGF-β1/Smad pathway
- (2019) Shi-Qiang Wang et al. Journal of Physiological Sciences
- Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
- (2019) John J.V. McMurray et al. NEW ENGLAND JOURNAL OF MEDICINE
- Inhibition of microRNA‐150‐5p alleviates cardiac inflammation and fibrosis via targeting Smad7 in high glucose‐treated cardiac fibroblasts
- (2019) Hui Che et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Hypoxia-inducible factor-1α is the therapeutic target of the SGLT2 inhibitor for diabetic nephropathy
- (2019) Ryoichi Bessho et al. Scientific Reports
- Metoprolol and bisoprolol ameliorate hypertrophy of neonatal rat cardiomyocytes induced by high glucose via the PKC/NF‑κB/c‑fos signaling pathway
- (2019) Min Wang et al. Experimental and Therapeutic Medicine
- Neuregulin-1 Promotes Myocardial Angiogenesis in the Rat Model of Diabetic Cardiomyopathy
- (2018) Chun Gui et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Role of SGLT1 in high glucose level-induced MMP-2 expression in human cardiac fibroblasts
- (2018) Liping Meng et al. Molecular Medicine Reports
- Telmisartan and thiorphan combination treatment attenuates fibrosis and apoptosis in preventing diabetic cardiomyopathy
- (2018) Vajir Malek et al. CARDIOVASCULAR RESEARCH
- RNA-seq analyses the effect of high-salt diet in hypertension
- (2018) Huifeng Xu et al. GENE
- A sodium-glucose cotransporter 2 (SGLT2) inhibitor dapagliflozin comparison with insulin shows important effects on Zn2+-transporters in cardiomyocytes from insulin-resistant metabolic syndrome rats through inhibition of oxidative stress
- (2018) Yusuf Olgar et al. CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY
- Dapagliflozin Attenuates Na+/H+ Exchanger-1 in Cardiofibroblasts via AMPK Activation
- (2018) Yumei Ye et al. CARDIOVASCULAR DRUGS AND THERAPY
- Empagliflozin, an SGLT2 inhibitor, reduced the mortality rate after acute myocardial infarction with modification of cardiac metabolomes and anti-oxidants in diabetic rats.
- (2018) Hiroto Oshima et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes
- (2018) Stephen D. Wiviott et al. NEW ENGLAND JOURNAL OF MEDICINE
- Matrine suppresses cardiac fibrosis by inhibiting the TGF‑β/Smad pathway in experimental diabetic cardiomyopathy
- (2017) Yong Zhang et al. Molecular Medicine Reports
- ATF5 regulates β-cell survival during stress
- (2017) Christine A. Juliana et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Unifying mechanism for different fibrotic diseases
- (2017) Gerlinde Wernig et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- p53 regulates the cardiac transcriptome
- (2017) Tak W. Mak et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Overexpression of decorin promoted angiogenesis in diabetic cardiomyopathy via IGF1R-AKT-VEGF signaling
- (2017) Jinsheng Lai et al. Scientific Reports
- The Transcription Factor ATF5 Mediates a Mammalian Mitochondrial UPR
- (2016) Christopher J. Fiorese et al. CURRENT BIOLOGY
- Metallothionein Is Downstream of Nrf2 and Partially Mediates Sulforaphane Prevention of Diabetic Cardiomyopathy
- (2016) Junlian Gu et al. DIABETES
- PDGF-A and PDGF-B induces cardiac fibrosis in transgenic mice
- (2016) Radiosa Gallini et al. EXPERIMENTAL CELL RESEARCH
- miR-30c and miR-181a synergistically modulate p53–p21 pathway in diabetes induced cardiac hypertrophy
- (2016) Satish K. Raut et al. MOLECULAR AND CELLULAR BIOCHEMISTRY
- The Expression Level of mRNA, Protein, and DNA Methylation Status of FOSL2 of Uyghur in XinJiang in Type 2 Diabetes
- (2016) Jun Li et al. Journal of Diabetes Research
- Effects of hydrogen sulfide on myocardial fibrosis in diabetic rats: Changes in matrix metalloproteinases parameters
- (2015) Ting Xiao et al. BIO-MEDICAL MATERIALS AND ENGINEERING
- Study on the mechanism of HIF1a-SOX9 in glucose-induced cardiomyocyte hypertrophy
- (2015) Qianqian Gao et al. BIOMEDICINE & PHARMACOTHERAPY
- Macrophage migration inhibitory factor promotes expression of GLUT4 glucose transporter through MEF2 and Zac1 in cardiomyocytes
- (2015) Yeyou Liang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Inhibition of prolyl hydroxylase 3 ameliorates cardiac dysfunction in diabetic cardiomyopathy
- (2015) Yanfei Xia et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- An Altered Pattern of Myocardial Histopathological and Molecular Changes Underlies the Different Characteristics of Type-1 and Type-2 Diabetic Cardiac Dysfunction
- (2015) Tamás Radovits et al. Journal of Diabetes Research
- Obesity in a model of gpx4 haploinsufficiency uncovers a causal role for lipid-derived aldehydes in human metabolic disease and cardiomyopathy
- (2015) Lalage A. Katunga et al. Molecular Metabolism
- Genetically Low Antioxidant Protection and Risk of Cardiovascular Disease and Heart Failure in Diabetic Subjects
- (2015) Camilla J. Kobylecki et al. EBioMedicine
- Diabetic cardiomyopathy is associated with defective myocellular copper regulation and both defects are rectified by divalent copper chelation
- (2014) Shaoping Zhang et al. Cardiovascular Diabetology
- Identification of Annexin A4 as a hepatopancreas factor involved in liver cell survival
- (2014) Danhua Zhang et al. DEVELOPMENTAL BIOLOGY
- Hyperglycemia causes cellular senescence via a SGLT2- and p21-dependent pathway in proximal tubules in the early stage of diabetic nephropathy
- (2014) Kento Kitada et al. JOURNAL OF DIABETES AND ITS COMPLICATIONS
- Vascular Endothelial Growth Factor Signaling in Hypoxia and Inflammation
- (2014) S. Ramakrishnan et al. Journal of Neuroimmune Pharmacology
- Significance of AT1 Receptor Independent Activation of Mineralocorticoid Receptor in Murine Diabetic Cardiomyopathy
- (2014) Yuji Nagatomo et al. PLoS One
- Partial deficiency of HIF-1α stimulates pathological cardiac changes in streptozotocin-induced diabetic mice
- (2014) Romana Bohuslavova et al. BMC Endocrine Disorders
- Bach1 deficiency protects pancreatic β-cells from oxidative stress injury
- (2013) Keiichi Kondo et al. AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM
- Hydrogen sulfide preconditions the db/db diabetic mouse heart against ischemia-reperfusion injury by activating Nrf2 signaling in an Erk-dependent manner
- (2013) Bridgette F. Peake et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Reversal of mitochondrial proteomic loss in Type 1 diabetic heart with overexpression of phospholipid hydroperoxide glutathione peroxidase
- (2013) Walter A. Baseler et al. AMERICAN JOURNAL OF PHYSIOLOGY-REGULATORY INTEGRATIVE AND COMPARATIVE PHYSIOLOGY
- Hypoxia-inducible factor 1α mediates the down-regulation of superoxide dismutase 2 in von Hippel–Lindau deficient renal clear cell carcinoma
- (2013) Yao-Hui Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Limiting Cardiac Ischemic Injury by Pharmacological Augmentation of Macrophage Migration Inhibitory Factor–AMP-Activated Protein Kinase Signal Transduction
- (2013) Jingying Wang et al. CIRCULATION
- Effects of SGLT2 Inhibition in Human Kidney Proximal Tubular Cells—Renoprotection in Diabetic Nephropathy?
- (2013) Usha Panchapakesan et al. PLoS One
- Activation of HIF-1 by metallothionein contributes to cardiac protection in the diabetic heart
- (2012) Wanli Xue et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- α11 integrin stimulates myofibroblast differentiation in diabetic cardiomyopathy
- (2012) Ilana Talior-Volodarsky et al. CARDIOVASCULAR RESEARCH
- Metformin reverses hexokinase and phosphofructokinase downregulation and intracellular distribution in the heart of diabetic mice
- (2012) Daniel Da Silva et al. IUBMB LIFE
- FOSL2 promotes leptin gene expression in human and mouse adipocytes
- (2012) Christiane D. Wrann et al. JOURNAL OF CLINICAL INVESTIGATION
- New insights into adipocyte-specific leptin gene expression
- (2012) Christiane D. Wrann et al. Adipocyte
- Prolyl hydroxylase domain protein 3 targets Pax2 for destruction
- (2011) Bing Yan et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Azelnidipine prevents cardiac dysfunction in streptozotocin-diabetic rats by reducing intracellular calcium accumulation, oxidative stress and apoptosis
- (2011) Vasundhara Kain et al. Cardiovascular Diabetology
- Breviscapine ameliorates hypertrophy of cardiomyocytes induced by high glucose in diabetic rats via the PKC signaling pathway
- (2009) Min Wang et al. ACTA PHARMACOLOGICA SINICA
- Decreased cardiac expression of vascular endothelial growth factor and redox imbalance in murine diabetic cardiomyopathy
- (2009) Bing Han et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- The signal transduction pathway of PKC/NF-κB/c-fos may be involved in the influence of high glucose on the cardiomyocytes of neonatal rats
- (2009) Wang Min et al. Cardiovascular Diabetology
- Anti-inflammatory and anti-coagulatory activities of caffeic acid and ellagic acid in cardiac tissue of diabetic mice
- (2009) Pei-chun Chao et al. Nutrition & Metabolism
- Reduced MMP-2 activity contributes to cardiac fibrosis in experimental diabetic cardiomyopathy
- (2008) Sophie Linthout et al. BASIC RESEARCH IN CARDIOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now